Expected benefits of topotecan combined with lapatinib in recurrent ovarian cancer according to biological profile: a phase 2 trial (Q33403609)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Expected benefits of topotecan combined with lapatinib in recurrent ovarian cancer according to biological profile: a phase 2 trial |
scientific article |
Statements
1 reference
Expected benefits of topotecan combined with lapatinib in recurrent ovarian cancer according to biological profile: a phase 2 trial (English)
1 reference
Stéphanie Lheureux
1 reference
Sophie Krieger
1 reference
Béatrice Weber
1 reference
Patricia Pautier
1 reference
Michel Fabbro
1 reference
Frédéric Selle
1 reference
Hugues Bourgeois
1 reference
Thierry Petit
1 reference
Alain Lortholary
1 reference
Anne Plantade
1 reference
Mélanie Briand
1 reference
Alexandra Leconte
1 reference
Paul Vilquin
1 reference
Bénédicte Clarisse
1 reference
Cécile Blanc-Fournier
1 reference
1 November 2012
1 reference
1 reference
22
1 reference
1483-1488
1 reference
Identifiers
1 reference
1 reference